StockNews.AI
MODV
StockNews.AI
140 days

Attention Long-Term ModivCare, Inc. (NASDAQ: MODV) Shareholders: Grabar Law Office Investigates Claims on Your Behalf

1. Grabar Law is investigating ModivCare officers for potential fiduciary duty breaches. 2. Claims allege ModivCare misled shareholders about free cash flow risks. 3. Free cash flow deterioration negatively impacted adjusted EBITDA and liquidity. 4. Affected shareholders can seek reforms and fund returns at no cost. 5. Market reaction indicates significant stock price declines amid transparency issues.

4m saved
Insight
Article

FAQ

Why Bearish?

The allegations of misleading information about cash flow can lead to reduced investor trust and stock price declines. Similar cases in the past resulted in significant drops for companies facing fiduciary duty investigations.

How important is it?

The investigation can lead to substantial implications for ModivCare’s financial health and operational transparency, affecting shareholder confidence.

Why Short Term?

Immediate market reaction is likely to be negative due to investor sentiment and potential for ongoing legal proceedings. History shows that similar news leads to immediate stock price volatility.

Related Companies

MODVCNCHUM
PHILADELPHIA, April 01, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating claims on behalf of ModivCare, Inc. (NASDAQ: MODV) shareholders. The investigation concerns whether certain officers of ModivCare have breached the fiduciary duties they owed to the company. Current ModivCare shareholders who have held ModivCare shares since prior to November 3, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award - all at no cost to them whatsoever. To learn more visit: https://grabarlaw.com/the-latest/modivcare-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. Why: A recently filed securities fraud class action complaint alleges that ModivCare, Inc. (NASDAQ: MODV), through certain of its officers, misled the market to believe certain contracts used in its non-emergency medical transportation (“NEMT”) segment mitigated risks to its free cash flow. In reality, the Company’s free cash flow had deteriorated. When the truth began to reach the market, ModivCare’s stock price suffered significant declines, harming investors. Specifically, Defendants failed to disclose that certain contracts used in ModivCare’s NEMT segment caused the Company’s free cash flow to deteriorate and that, as a result, (1) contract renegotiations and pricing accommodations negatively impacted the Company’s adjusted EBITDA; (2) the Company had insufficient liquidity; and (3) Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. What To Do Now: Current ModivCare (NASDAQ: MODV) shareholders who have held ModivCare shares since prior to November 3, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award - all at no cost to them whatsoever. If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/methode-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. #ModivCare $MODV Attorney Advertising Disclaimer Contact:Joshua H. Grabar, Esq.Grabar Law OfficeOne Liberty Place1650 Market Street, Suite 3600Philadelphia, PA 19103Tel:  267-507-6085Email: jgrabar@grabarlaw.com

Related News